In order to be approved by the U.S. Food and Drug Association (FDA), potential new cancer therapies and drugs must go through clinical trials. Products awaiting approval can be anywhere from brand-new therapies to small additions to already-existing drugs. Public…

Published in the Wall Street Journal, February 7, 2014 Super Bowl Against Cancer Needs Rules, Referees, Too Wes Chapman                 Dr. John C. Lechleiter really demonstrates a striking misunderstanding of football as he…

Presentation at the Cancer Center Business Summit October 25, 2013 Chicago Wes Chapman

I spoke last week at the 2012 Cancer Center Business Summit.  Click on the link for the PowerPoint Slides given at the Summit: Cancer Business Summit v6. All the Best, Wes